GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rubicon Organics ROMJ.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.42

-2.33%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$59.5m

FY2017FY2025

Net income

C$1.1m

FY2017FY2025

Free cash flow

−C$11.5m

FY2017FY2025

Shareholders' equity

C$44.1m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueC$59.5mC$48.7mC$40.1mC$35.5mC$22.6mC$9.4mC$454,043C$2.0mC$884,364
Operating incomeC$1.8m−C$1.4m−C$722,279−C$2.8m−C$13.3m−C$12.9m−C$9.6m−C$9.3m−C$5.6m
Net incomeC$1.1m−C$2.6m−C$1.8m−C$3.9m−C$14.5m−C$15.0m−C$14.3m−C$29.9m−C$5.9m
Diluted earnings per share0.02-0.05-0.03-0.07-0.26-0.30-0.36-0.81-0.16

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsC$66.9mC$56.6mC$54.9mC$56.1mC$54.8mC$51.1mC$39.8mC$28.3mC$21.9m
Total liabilitiesC$22.8mC$19.2mC$17.0mC$17.8mC$15.9mC$22.2mC$21.3mC$6.3mC$5.2m
DebtC$10.3mC$8.5m—C$9.4mC$8.9m—C$8.4mC$2.8mC$2.9m
Shareholders' equityC$44.1mC$37.4mC$37.9mC$38.3mC$38.9mC$28.8mC$18.5mC$22.1mC$16.7m
Shares outstanding67m56m56m56m56m49m40m37m37m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−C$3.0mC$3.4mC$6.8mC$2.0m−C$10.4m−C$14.3m−C$10.1m−C$9.3m−C$4.2m
Capital spending−C$8.4m−C$1.5m−C$3.4m−C$4.5m−C$5.5m−C$6.0m−C$7.9m−C$9.1m−C$4.9m
Free cash flow−C$11.5mC$1.9mC$3.4m−C$2.5m−C$15.9m−C$20.3m−C$18.1m−C$18.4m−C$9.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueC$18.5mC$13.7mC$16.5mC$15.6mC$15.0mC$12.4mC$14.2mC$13.5m
Operating incomeC$676,000−C$2.5m−C$2.0mC$3.0mC$977,000−C$147,000C$292,368C$157,675
Net incomeC$411,000−C$2.8m−C$2.2mC$2.8mC$773,000−C$322,000−C$47,402−C$168,498
Diluted earnings per share0.01-0.04-0.030.040.01-0.01-0.00-0.00
Cash from operations−C$1.0mC$2.0m−C$3.0m———C$2.0m—
Capital spending—−C$2.0m−C$1.0m—−C$5.0m———
Free cash flow—C$0−C$4.0m—————
Total assetsC$70.5mC$66.0mC$66.9mC$65.6mC$62.0mC$55.4mC$56.6mC$55.7m
DebtC$9.9mC$10.1mC$10.3mC$8.0mC$8.1mC$8.3mC$8.5m—
Shareholders' equityC$42.3mC$41.6mC$44.1mC$46.1mC$42.8mC$37.6mC$37.4mC$36.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue18.7%44.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings30.4-10.6-15.4-11.2-7.1-11.9-5.2-2.3
Price to sales0.50.60.71.24.619.1162.034.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.